The cerebroprotective properties of the com petitive NMDA antagonist o-(E)-2-amino-4-methyl-5phosphono-3-pentenoic acid (CGP 40116) were evaluated in a rat model of focal cerebral ischemia. CGP 40116 (5-40 mg/kg i.v.) was injected immediately following permanent occlusion of the left middle cerebral artery (MCA). MK 801 (1 or 3 mg/kg i.v.), o-CPPene (20 mg/kg i.v.), and CGS 19755 (40 mg/kg i.v.) were used for comparison. Lesion volume was assessed using in vivo magnetic res onance imaging, which in initial experiments with parallel histological determinations proved to be an accurate method for the measurement of brain infarction and the determination of a cerebroprotective drug effect. CGP 40116 dose-dependently reduced the volume of cortical
There are several lines of evidence supporting the hypothesis that overactivation of excitatory amino acid receptors by endogenous glutamate underlies the acute neuronal damage that occurs after cere bral ischemia. Key observations are that extracel lular glutamate and aspartate levels are elevated in animal models of brain ischemia (Benveniste et aI. , 1984; Hillered et aI. , 1989) and that removal of glu tamatergic afferents attenuates ischemia-induced cell damage in the hippocampus (Wieloch et aI., infarction, with an EDso of 11 mg/kg i.v. and a maximal effect equivalent to a 62% reduction in cortical edema volume. Its cerebroprotective efficacy was thus compa rable to that of MK 801. The rank order of potency for the NMDA antagonists was MK 801 > CGP 40116 -0-CPPene > CGS 19755. Neuroprotection by CGP 40116 was still apparent when treatment was started 30 min af ter MCA occlusion. It is concluded that CGP 40116 is an effective cerebroprotectant with potential clinical utility for amelioration of focal cerebral ischemic damage. Key Words: Focal cerebral ischemia-Magnetic resonance im aging-CGP 40116--NMDA antagonists-Neuroprotect ion-Rat.
1985; Onodera et aI. , 1986) . However, the most persuasive results indicative of a central role of ex citatory amino acid receptor mechanisms in the pathophysiology of cerebral ischemia arose from experiments showing that postischemic neurode generation can be attenuated by treatment with glu tamate receptor antagonists, particularly those act ing at the N-methyl-D-aspartate (NMDA) receptor subtype (for recent reviews, see Meldrum, 1990; McCulloch et aI. , 1991; . Un competitive NMDA receptor blockers [e.g., dizo cilpine (MK 801), phencyclidine (PCP), or dex tromethorphan] have consistently been shown to reduce neuronal damage in animal models of stroke (Park et aI., 1988; Steinberg et aI., 1988; Bielenberg and Beck, 1991) . Competitive NMDA receptor an tagonists, on the other hand, have been less stud ied, largely because of the low blood-brain barrier penetration of early compounds of this category (Watkins and Olverman, 1987) . Recently, competi tive antagonists have been developed that block NMDA receptors effectively after systemic applica tion (Fagg et aI. , 1990; Lowe et aI. , 1990) . Evalua tion of the therapeutic properties of these com pounds is of interest, because animal experiments suggest that they might exhibit less behavioral side effects than uncompetitive NMDA antagonists when given in therapeutically relevant doses and may thus have greater clinical utility (see Willetts et aI. , 1990 for discussion).
Here we describe the cerebroprotective proper ties of o-(E)-2-amino-4-methyl-5-phosphono-3pentenoic acid (CGP 40116), a potent competitive NMDA antagonist with oral bioavailability (Fagg et aI. , 1990; Sauer et aI. , 1992) , in a rat model of per manent middle cerebral artery (MCA) occlusion (Tamura et aI. , 1981) . Ischemic brain damage was quantified in vivo by means of magnetic resonance imaging (MRI) techniques . For comparison with CGP 40116, we also tested MK 801 and the two competitive NMDA an tagonists o-(E)-4-(3-phosphonoprop-2-enyl)pipera zine-2-carboxylic acid (o-CPPene, Lowe et aI. , 1990 ) and (± )-cis-4-phosphonomethylpiperidine-2carboxylic acid (CGS 19755, Lehmann et aI. , 1988) , which have previously been reported to protect neural tissue from the effects of focal cerebral isch emia (Bullock et aI. , 1990a,b; Simon and Shiraishi, 1990) .
MATERIALS AND METHODS

Induction of focal cerebral ischemia
A total of 176 male Fisher 344 rats (220-320 g weight; Iffa-Credo, France) was used for these experiments, grouped as follows: (a) 5 animals for initial time-course studies, (b) 26 animals for comparisons of MRI and his tology, and (c) 145 animals for evaluation of drug effects. Prior to surgery, animals were anesthetized with 2% iso flurane in a 70/30 (by volume) nitrous oxide/oxygen mix ture. Catheters were inserted in the tail artery and in the right femoral vein for measurement of the MABP and for i.v. drug application, respectively. Irreversible occlusion of the left MCA was performed as described by Tamura et al. (1981) with the aid of an operating microscope (Wild AG, Heerbrugg, Switzerland). The MCA was exposed by a subtemporal craniectomy and, after opening of the dura mater, the vessel and its lenticulostriate branches were occluded by bipolar electrocoagulation (Surgitron, Ell man, Hewlett, NY, U.S.A.). Retracted soft tissues were replaced, wounds were sutured, and anesthesia was dis continued. The body temperature was maintained at 37°C by means of a rectal probe and a feedback heating unit (CMA 115, Carnegie Medicine, Stockholm, Sweden) dur ing surgery and until animals regained consciousness. An imals were returned to their cages and were allowed free access to food and water until MRI measurements were performed or until killing for histology.
Magnetic resonance imaging
The volume of cerebral edema was determined in vivo by quantitative MRI according to Sauter and Rudin (1986) . Imaging was performed 2 days after MCA occlu sion unless stated otherwise. Measurements were made on a 4.7 T 30 cm bore Spectrospin BIOSPEC (Bruker, Karlsruhe, Germany) equipped with a 15 cm gradient coil. MRI equipment was calibrated before the experi ments using a cubic phantom of known dimensions. Each rat was anesthetized with Equithesin [25 ml of Vetanarcol (pentobarbital sodium, 162 mg/ml; benzyl alcohol, 20 mg/ml), 21.25 g of chloral hydrate, 10.63 g of MgS04, 198 ml of propan-l ,2-diol, and 50 ml of ethanol in 500 ml of distilled water; 3 ml/kg i.p.; Foster et aI., 1988] and po sitioned with its head in a resonator (diameter = 4 cm). The animal was subjected to one imaging cycle, in which 11 T 2 -weighted coronal slices of the brain with a thickness of 1.35 mm and a center-to-center interslice distance of 1.5 mm were taken using a multi slice spin-echo sequence [optimized parameters: repetition time of 2,030 ms; echo time of 60 ms; spatial resolution in plane (156 mm 2 ); total measuring time of 18 min].
Histology
A series of 26 animals was subjected to histological evaluation in addition to MRI. These were perfused transcardially with a phosphate-buffered 4% formalin so lution under deep Equithesin anesthesia immediately fol lowing MRI measurements. Brains were removed, post fixed in the same fixative at room temperature for at least 2 days, and thereafter embedded in paraffin wax (Para plast). Each brain was cut coronally into 5 fLm thick serial sections, and single sections spaced 500 fLm apart were stained with cresyl fast violet (Certistan, Merck, Darm stadt, Germany; 1 % solution) for determination of infarct volume.
Image analysis
Edematous tissue showed an approximately 50% higher signal intensity in MRI than healthy brain tissue, and its area was measured automatically in each slice by means of an off-line image analyzer (Bruker Aspect X32 workstation; Bruker, Karlsruhe, Germany). Edema was determined separately for cortex, corpus striatum, and total hemisphere. Following histological preparation, the area of degenerated tissue in each section was determined with the aid of a VIDS V imaging system (Bestobell Mo brey, Dusseldorf, Germany) that had been previously cal ibrated by measuring areas of known size. In each case, the volume of infarction was calculated based on the dam aged area in each slice and the distance between slices, assuming that interslice volumes were described by a truncated cone.
Drug administration
A total of 145 rats was included in this study. Drugs were dissolved in a 0.9% NaCI solution and injected slowly i.v. (1 mllkg of body weight; total injection time of 5 min) with a CMA/100 microinjection pump (Carnegie, Stockholm, Sweden). Control animals received the same amount of vehicle. Unless stated otherwise, drugs/vehicle were administered within the first 5 min after MCA oc clusion.
Data analysis
For evaluation of drug effects, experiments were con ducted such that one control and two treatment groups were operated and evaluated in parallel. Within each ex perimental series, rats were randomly assigned to one of the three groups. Table 1 shows the treatment groups paired with each control group and the number of animals involved.
All values reported are means ± SD. Statistical com parisons between control and treatment groups were made within each experimental series by means of a one way analysis of variance (ANOV A). The effect of drugs on MABP was determined by using each animal as its own control, and pre-versus postdrug comparison was made using Student's t test. All statistical comparisons were made using a software package (StatView) for the Apple Macintosh. p < 0.05 was regarded as being statis tically significant.
RESULTS
Initial experiments
Five untreated control rats were subjected to MRI measurements on 4 consecutive days (one im aging cycle every 24 h) to identify the optimal time point for brain edema determination. Postischemic brain damage was maximal in these animals 1-2 days after MCA occlusion and already slightly, but not significantly, diminished on day 4 (data not shown). This result is in good agreement with data published previously (Sauter and Rudin, 1986; Ger mano et ai., 1989; Knight et ai., 1991) .
In subsequent experiments, the amount of cere bral edema was determined 2 days after the induc tion of focal brain ischemia.
Comparison of MRI results with histological data
To determine whether cerebral edema as de tected by MRI accurately reflects postischemic neurodegeneration, brain damage following MCA Each experimental series comprised one group of control an imals (MCA occlusion, saline administration) and two groups that received drug treatments following MCA occlusion. n c and nD are the numbers of animals in the control and drug-treated groups, respectively. Treatment X is a drug treatment that was included in series C and E and that, although included for sta tistical purposes, is irrelevant to this study. occlusion was measured using MRI and established histological techniques in the same rats (n = 26). Nine of these animals received an i.p. injection of MK 801 (3 mg/kg), and the other rats remained un treated.
In all animals, occlusion of the left MCA resulted in damage of ipsilateral cortical and striatal tissue. Damage in brain regions other than the cortex or striatum was not seen. The regional distribution of the lesion throughout the brain appeared to be iden tical whether determined by MRI or histology (Fig.  1 ). Furthermore, quantitative comparison of the volume of affected tissue as measured by means of MRI and histology revealed a high correlation be tween these two methods (correlation coefficient: r = 0.94, P = 0.0001, simple regression analysis; Fig.  2a ). However, MRI indicated a larger absolute vol ume of cerebral infarction than did histological anal ysis (slope = 2.5; Fig. 2a ). Similarly, the total hemi spheric volume as measured by MRI was greater than that determined by histology (slope = 2.0; data not shown). This difference in infarct volume appears to result from tissue shrinkage during his tological preparation, since in the 164 brain slices from this series that showed measurable edema by MRI together with their matching histological sec tions (e.g., see Fig. 1 ), there was an almost 1:1 cor relation between the percent area of the lesioned left hemisphere in each slice showing damage as measured by either technique (slope = 1.01; r = 0.93, p = 0. 0001, simple regression analysis; Fig.  2b ).
When the MK 80I-treated rats were compared with matching untreated control animals (n = 8), the amount of neuroprotection achieved by treat ment with the NMDA antagonist was similar using both methods of ischemic brain damage determina tion. MK 801 significantly reduced the total volume brain edema and infarction by 49 ± 9 and 54 ± 15% compared to control animals when determined by means of MRI and histological techniques, respec tively (p < 0.05, MK 80I-treated vs. control animals for both methods).
Effects of NMDA receptor antagonists on postischemic brain damage Intravenous application of the different NMDA receptor antagonists (MK 801, 1 or 3 mg/kg; CGP 40116, 5, 10, 20, or 40 mg/kg; CGS 19755, 40 mg/kg;  or D-CPPene, 20 mg/kg) after MCA occlusion caused a decrease in MABP immediately after the injection. Ten minutes later, MABP measurements were discontinued. At that time point, the MABP had normalized in those rats receiving 5 or 10 mg/kg of CGP 40116, but was still significantly lower than preinjection values in the other treatment groups ( Table 2) .
Administration of any of the NMDA antagonists after MeA occlusion reduced the volume of cortical The MABP was measured via a catheter inserted into the tail artery before and 10 min following injection of the different NMDA antagonists (control animals received saline). The values are given as means ± SD of n animals. a p < 0.05, post-vs. preinjection values (Student's t test). edema without influencing striatal edema (Fig. 3) . cap 40116 dose-dependently decreased the cortical lesion measured by MRI, reaching a 55 ± 13% re duction (relative to controls) at a dose of 40 mg/kg (Fig. 4 ). Curve fitting (logistic equation) indicated an ED50 of 11 mg/kg i. v. for this compound, with a maximal protective effect equivalent to a 62% re duction in cortical edema volume. The cerebropro tective action of D-CPPene (20 mg/kg) was very similar to that of the same dose of cap 40116 (48 ± 21 and 50 ± 16% reduction in cortical damage, re spectively), while cas 19755 (40 mg/kg) was weaker, with only a 37 ± 14% reduction in cortical edema volume compared with 55 ± 13% for cap 40116 at this dose level. The uncompetitive NMDA receptor antagonist MK 801 was the most potent cerebroprotectant tested (62 ± 10% reduction in cortical damage at 3 mg/kg). The results of all ex periments are summarized in Fig. 4 .
Effect of delayed cap 40116 application on brain edema volume
When the injection of cap 40116 (40 mg/kg i.v.) was started 30 min after induction of focal cerebral ischemia, a significant reduction in cortical edema volume could still be demonstrated (34 ± 15% less damage than in the control group; Fig. 5 ; p < 0.05). No neuroprotection was achieved, however, when the NMDA antagonist was given 1 h after MCA occlusion (Fig. 5 ).
DISCUSSION
The goal of the present study was to evaluate the neuroprotective properties of the novel competitive NMDA receptor antagonist, cap 40116, in a rat model of ischemic stroke and, under the same ex perimental conditions, to compare this with D CPPene, cas 19755, and MK 801. As a prelude to this study, we conducted a rigorous analysis of the use of MRI for estimating cerebral infarction and its prevention, and that is also reported here.
Correlation of MRI-and histologically determined brain damage
Recently, MRI techniques have been employed by several groups to assess the extent of cerebral damage following brain ischemia in small animals (Sauter and Rudin, 1986; Steinberg et aI., 1988; Bradley et aI., 1989; Germano et aI., 1989; Barone et aI., 1991; Benveniste et aI., 1991) . Although most authors reported that results obtained with MRI correspond well to those obtained by using estab lished histological techniques, we are aware of only one quantitative study showing a positive correla tion between postischemic cerebral edema as deter mined by MRI and neuronal loss measured histo logically in single brain sections (Barone et aI., 1991) . Benveniste et ai. (1991) , on the other hand, reported that the cerebral lesion defined by MRI after permanent combined occlusion of the right MCA and common carotid arteries was much larger than the area of necrotic brain tissue determined by histology and hence that the brain lesion size may be overestimated by MRI. However, these authors analysed single slices and did not determine the whole volume of the lesion for the comparison of MRI and histological data.
Our results clearly demonstrate that cerebral in farction induced by permanent MCA occlusion is accurately and reproducibly measured by in vivo MRI. There is an excellent correlation (r = 0.94) between the volumes of edematous tissue deter mined by MRI and of necrotic tissue measured using established histological methods. Furthermore, the degree of cerebroprotection achieved by treatment with the uncompetitive NMDA receptor antagonist, MK 801, was the same when analyzed by either tech nique, indicating that MRI is a valuable method for the examination of potentially neuroprotective drugs.
Despite this strong correlation, the absolute vol ume of the ischemic brain lesion determined by his tological techniques was �40% of that measured by MRI. Shrinkage of the brains due to dehydration during histological preparation seems to be the main reason for this difference, since the percent damage (edema or necrosis) in affected brain slices was al most identical whether measured by MRI or histo logical analysis. The magnitude of volumetric re duction corresponds to an �20--25% decrease in linear tissue dimensions through histological prep aration. The small difference in lesion volume be tween the two techniques that is unaccounted for by tissue shrinkage (maximally 5%) conceivably could be due to a greater loss of water from edematous tissue than from healthy tissue during histological preparation or to a small extension of edema into brain tissue in which neuronal necrosis does not occur. Either way, it is clear that MRI and histo logical techniques are measuring essentially the same damaged brain tissue following cerebral in farction as induced in this model. Vol. 13, No.4, 1993 Neuroprotective efficacy of NMDA receptor antagonists NMDA receptor antagonists were first reported to be neuroprotective by Simon et ai. (1984) and, since that time, a large number of investigations have focused on the protective properties of such agents in models of excitotoxic and ischemic brain damage (for review, see McCulloch et aI., 1991) . By far the largest number of studies in vivo have cen tered on uncompetitive (channel) blockers, such as MK 801, PCP, and ketamine, primarily because competitive NMDA antagonists with the necessary potency and bioavailability were not available.
Here, we report that the competitive NMDA recep tor antagonist CGP 40116 efficaciously reduces brain damage in a rat model of focal cerebral isch emia. In agreement with earlier studies using MK 801 and other NMDA antagonists (see McCulloch et aI., 1991) , the maximum protection achieved was �60% of the cortical edema volume, corresponding to the penumbra zone of the ischemic infarct in this rat model of permanent MCA occlusion (Shiraishi et aI., 1989) . Damage to the striatum cannot be re duced significantly in this model, owing to the lack of coIlateral blood supply in that brain region (see McCuIloch et aI., 1991) .
Comparison of the cerebroprotective effects of CGP 40116, CGS 19755, D-CPPene, and MK 801 indicated that MK 801 is the most potent of the four NMDA antagonists examined. There are several possible explanations for this finding: (a) MK 801 is a lipophilic drug that, when injected peripheraIly, may cross the blood-brain barrier to a greater ex tent than the polar competitive NMDA antagonists. (b) MK 801 has a higher receptor binding potency compared to the competitive NMDA antagonists (Wong et aI., 1988; Fagg et aI., 1990) , and it thus could be that the relative anti-ischemic potencies of the different NMDA antagonists reflect their rela tive binding potencies at their respective membrane binding site. (c) The uncompetitive mechanism of action of MK 801 could favor neuroprotection by this drug, as it is known that the extraceIlular glu tamate concentration is increased following cere bral ischemia (Benveniste et aI., 1984) , and this could impair binding of competitive antagonists to the transmitter recognition site of the NMDA recep tor but, on the other hand, facilitate MK 801 binding (Kemp et aI., 1987) . Thus, a higher brain concen tration of the competitive antagonist would be needed to overcome NMDA receptor activation caused by a high extraceIlular glutamate concentra tion. However, results from a recent investigation in our laboratory using a model of quinolinic acid induced neurotoxicity indicate that the mechanism of action of NMDA receptor antagonists at the re ceptor does not critically affect their neuroprotec tive efficacy following systemic application (Mas sieu et aI., 1991; and unpublished results) .
With regard to the three competitive antagonists tested in our experiments, CGP 40116 and D CPPene were approximately equipotent, while CGS 19755 appeared to be less effective. Given that the maximal protection by NMDA antagonists ob served in such models is about a 60% reduction in cortical infarction and that the dose of CGS 19755 chosen reduces cortical damage by 37% (close to half maximal), CGS 19755 appears to be approxi mately three-to fourfold weaker than CGP 40116. A similar rank order for these three competitive NMDA antagonists was found in our laboratory us ing a model of direct quinolinic acid-induced neuro toxicity (Sauer et aI., 1992 ; Massieu et aI. , submit ted for publication). D-CPPene recently has been shown to reduce cortical infarction after MCA oc clusion in cats (Bullock et aI. , 1990a,b) and CGS 19755 has been reported to be protective in focal cerebral ischemia in rats (Simon and Shiraishi, 1990; Takizawa et aI. , 1991) . The results of those studies, however, can not be directly compared with our investigation, since they used either a dif ferent animal species (Bullock et aI. , 1990a) , a dif ferent experimental model (Bullock et aI., 1990b; Takizawa et aI., 1991) , or a different method of in farct quantification (Shiraishi et aI. , 1990) . Our study is the first to examine the cerebroprotective efficacy of three competitive and one uncompetitive NMDA antagonist under the same experimental conditions, thus allowing direct comparison of the data.
CGP 40116 showed some postischemic efficacy as the compound was cerebroprotective when ad ministered 30 min following the induction of focal cerebral ischemia, but not when injected 60 min af ter MCA occlusion. Postischemic efficacy also has been reported for MK 801 and PCP, which reduced the infarct size when administered 2 or 3 h after MCA occlusion, respectively (Park et aI. , 1988; Bie lenberg and Beck, 1991) , while D-CPPene and CGS 19755 were both inactive when treatment was initi ated 1 h after the onset of brain ischemia (Bullock et aI., 1990b; Simon and Shiraishi, 1990) . Whether these results reflect a true difference in the post ischemic efficacy of competitive and uncompetitive NMDA antagonists is unclear and will remain so until a comparative study addressing this question is performed.
In conclusion, our data demonstrate (i) that MRI is a valuable method for quantitative determination of brain infarction and neuroprotection following MCA occlusion in rats, (ii) that the competitive NMDA receptor antagonist CGP 40116 is a potent neuroprotectant in this model of focal brain isch emia, with a cerebroprotective efficacy similar to that of MK 801, and (iii) that CGP 40116 is effective when administered after the ischemic insult. Com petitive NMDA antagonists such as CGP 40116 may prove to be of clinical value for the treatment of ischemic brain damage in humans.
